Upload
Featured Recent Articles Topics Login Upload

Search Results for 'fda'

fda published presentations and documents on DocSlides.

Phil Johnson MS RPh Safe School Meds, Principle Partner
Phil Johnson MS RPh Safe School Meds, Principle Partner
by yoshiko-marsland
Moffitt Cancer Center, Director of Pharmacy (Reti...
Biomarkers for Cancer Immunotherapy: Understanding Their Growing Role in
Biomarkers for Cancer Immunotherapy: Understanding Their Growing Role in
by yoshiko-marsland
Pan Tumors. This program will include a discussio...
Combating the Drug Shortage Crisis
Combating the Drug Shortage Crisis
by danika-pritchard
. . Moderator. Ron Hartmann, . PharmD. , Senio...
Needed Regulatory Changes
Needed Regulatory Changes
by liane-varnes
A report of the typist for the Regulation Subgrou...
FDA Regulatory Framework for
FDA Regulatory Framework for
by giovanna-bartolotta
Devices Applied to HIT. Bradley Merrill Thompson....
State Success Stories — Best Practices in Recalls/Best Practices in
State Success Stories — Best Practices in Recalls/Best Practices in
by luanne-stotts
Tracebacks. and . Traceforwards. . . Facilitat...
Diane L. Heinz, DVM, MBA
Diane L. Heinz, DVM, MBA
by olivia-moreira
Director. Policy and Regulations Staff. Center fo...
The Impact of FSMA Rules on
The Impact of FSMA Rules on
by alida-meadow
Sustainable Agriculture and . Local Food Systems....
FDA Regulatory Framework for
FDA Regulatory Framework for
by marina-yarberry
Devices Applied to HIT. Bradley Merrill Thompson....
Understanding FDA’s Food Supplier Verification Program (FSVP)
Understanding FDA’s Food Supplier Verification Program (FSVP)
by min-jolicoeur
MODERATOR:. Mike. Lahar . A.N. . Deringer. NCBFA...
Regulatory weaknesses A report of the typist for the Regulation Subgroup
Regulatory weaknesses A report of the typist for the Regulation Subgroup
by phoebe-click
(i.e. no one has seen or approved this). Draft 07...
FDA Final Rule & Revised NCI Guidelines for Expedited Reporting of Adverse Events
FDA Final Rule & Revised NCI Guidelines for Expedited Reporting of Adverse Events
by lois-ondreau
S. Percy Ivy, MD. Associate Chief, Senior Investi...
DRAFT FDASIA Committee Report
DRAFT FDASIA Committee Report
by briana-ranney
David W. Bates MD, . MSc. , Chair. 1. Committee M...
-Drafted in 1938 -Amendment Years were in 1954 and 1958
-Drafted in 1938 -Amendment Years were in 1954 and 1958
by mitsue-stanley
-National law in United States. Federal Food, Dru...
Drug Supply Chain Security Act, Implications for the Hospital Pharmacy
Drug Supply Chain Security Act, Implications for the Hospital Pharmacy
by faustina-dinatale
Pamela Kindall, BBA. Pharmacy Business Specialist...
CITMA Seminar The Fsptca :
CITMA Seminar The Fsptca :
by tawny-fly
an overview. 1. Stacy Ehrlich, Esq.. Partner. Kle...
Patient Engagement in Drug Development
Patient Engagement in Drug Development
by debby-jeon
:. Experiences, Good Practices and Lessons Learne...
Corporate Counsel Women of Color
Corporate Counsel Women of Color
by giovanna-bartolotta
12. th. Annual Career Strategies Conference. Lif...
Presented by: John S. Graham, Ph.D., MBA, DABT
Presented by: John S. Graham, Ph.D., MBA, DABT
by giovanna-bartolotta
Director, CVM Office of Research. U.S. Food and D...
Faculty Leonard H. Calabrese, DO
Faculty Leonard H. Calabrese, DO
by trish-goza
Professor of Medicine. Cleveland Clinic Lerner Co...
Diane L. Heinz, DVM, MBA
Diane L. Heinz, DVM, MBA
by debby-jeon
Director. Policy and Regulations Staff. Center fo...
The IND and Clinical Trial Management
The IND and Clinical Trial Management
by kittie-lecroy
Frances Richmond . Director International Center ...
Incentives for Drug Approval - How & Why to Use Them
Incentives for Drug Approval - How & Why to Use Them
by lindy-dunigan
Aquaculture Drug Workshop. Bozeman, Montana. July...
THE FUTURE IS NOW http://www.fda.gov/fsma
THE FUTURE IS NOW http://www.fda.gov/fsma
by ellena-manuel
Final Rule: Protecting Food Against Intentional ...
Protecting the U.S. Drug Supply Chain
Protecting the U.S. Drug Supply Chain
by kittie-lecroy
Sangeeta Vaswani Chatterjee, . Pharm.D. .. Branch...
Current FDA Enforcement Trends –
Current FDA Enforcement Trends –
by stefany-barnette
Avoiding A Criminal Investigation. . July 12, 2...
Importance of Instructions for Use: What is Changing
Importance of Instructions for Use: What is Changing
by test
Cynthia Spry, MA,MS,RN,CNOR(E),CSPDT. Independent...
Safety of food additives: The regulatory Roadmap
Safety of food additives: The regulatory Roadmap
by mitsue-stanley
Manojit Basu, PhD . Grocery Manufacturers Associa...
Can I Make an App for That?
Can I Make an App for That?
by mitsue-stanley
How FDA and HIPAA regulations apply to medical mo...
Precision Medicine: Levels of Evidence Required for Reporting Variants and Guiding Patient Treatmen
Precision Medicine: Levels of Evidence Required for Reporting Variants and Guiding Patient Treatmen
by ellena-manuel
Apostolia M. Tsimberidou, . MD, PhD. Professor . ...
Public Meeting: Pre-DSHEA Dietary Ingredients List
Public Meeting: Pre-DSHEA Dietary Ingredients List
by celsa-spraggs
FDA Office of Dietary Supplement Programs. Panel ...
FDA Final Rule & Revised NCI Guidelines for Expedited Reporting of Adverse Events
FDA Final Rule & Revised NCI Guidelines for Expedited Reporting of Adverse Events
by mitsue-stanley
S. Percy Ivy, MD. Associate Chief, Senior Investi...
1 Changing Smoking Habits
1 Changing Smoking Habits
by alexa-scheidler
2. Politics of Tobacco Regulation. FDA v. Brown &...
FDA Public Workshop – Variant Classification
FDA Public Workshop – Variant Classification
by lindy-dunigan
Session 4: Future directions for data sharing, st...
Regulatory Framework for
Regulatory Framework for
by tawny-fly
Food Safety at FDA. July 12, 2018. What is Food?....
Citizen Petitions, REMS
Citizen Petitions, REMS
by tawny-fly
, . and Antitrust . Law. Seth . C. Silber. Partne...
Safety of food additives: The regulatory Roadmap
Safety of food additives: The regulatory Roadmap
by kittie-lecroy
Manojit Basu, PhD . Grocery Manufacturers Associa...
FDA 21 CFR Part 11 Compliance
FDA 21 CFR Part 11 Compliance
by debby-jeon
Charles Yan, PhD. Senior Director, Clinical Data ...
THE NAME GAME Lisa M. Tittemore,
THE NAME GAME Lisa M. Tittemore,
by pasty-toler
Esq.. Sunstein Kann Murphy & Timbers LLP. Ju...
FSMA Communications and Engagement for International
FSMA Communications and Engagement for International
by myesha-ticknor
Stakeholders. March 21, . 2016. Julie . Moss, PhD...